Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03520959
Title Synovate Study for Synovial Sarcoma, Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Immune Design
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA | CAN


No variant requirements are available.